KLK3 and metastatic prostate carcinoma: We describe two patients with metastatic prostate cancer who developed rapid clinical progression accompanied by disproportionately low prostate-specific antigen (PSA) levels, ultimately revealing transformation to neuroendocrine carcinoma.